Congratulations to our CEO, Dr. Bruce McManus, who was appointed as a Member of the Order of Canada on Friday, June 29th, 2018.
Dr. McManus was recognized for his translational research that has led to advancements in the diagnosis and …
PROOF’s Biomarkers in Transplantation (BiT) program focuses on applying a novel multi-gene blood test to the management of acute cardiac allograft rejection, with the end goal of improving patient management while reducing the need for biopsies. We have recently developed …
2017 has been a year of widespread global attention to blockchain possibilities beyond mere finance, and the PROOF Centre, together with Blockchain@UBC (http://www.blockchainubc.ca/) and other partners, is exploring these applications within the contexts of health research, ethics, …
Congratulations to Dr. Scott Tebbutt for being one of the recipients of a 2017 NIH Human Immunology Project Consortium grant (U19), led by Dr. Ofer Levy at Children’s Hospital in Boston. Dr. Tebbutt’s project aims to investigate immune response to …
PROOF’s Biomarkers in Transplantation (BiT) program focuses on applying a novel multi-gene blood test to the management of acute cardiac allograft rejection, with the end goal of improving patient management while reducing the need for biopsies. Congratulations to Dr. McManus …